Sorrento Therapeutics Net Tangible Assets

Sorrento Therapeutics (SRNE) currently reports a net tangible assets of $-200M as of June 2023. That compares with $140M in the prior-year period — down 245.8% year over year. Use the charts on this page to explore Sorrento Therapeutics's net tangible assets history and peer comparisons.

Sorrento Therapeutics's net tangible assets decreased from $140M to $-200M — a 245.8% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sorrento Therapeutics reported $-200M in net tangible assets as of June 2023. That compares with $140M in the prior-year period — down 245.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-200M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sorrento Therapeutics, and consider following SRNE for alerts when major investors trade the stock.

Sorrento Therapeutics is classified in the Healthcare sector. On net tangible assets, it currently shows $-200M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SRNE with unrelated industries.